New in-depth report now available from the 2nd Annual Meeting of the European CME Forum
24 February, NetworkPharma Ltd, Oxford, UK have published another in their KeywordPharma series of Conference Insights Reports intended for individuals working in and around the global pharmaceutical industry.
The new in-depth report from the 2nd Annual Meeting of the European CME Forum is now available to purchase, written by Eugene Pozniak and David Williams.
Shaping the future for continuing medical education (CME) in Europe is bedevilled by many challenges. Mindful of the mantra that ‘when America sneezes, Europe catches a cold’, European healthcare stakeholders can, and must, learn from mistakes made in the USA when developing a robust framework for CME in the region. The 2nd Annual Meeting of the European CME Forum drew together many of the influential players from Europe and beyond who hold the key to the development of CME in Europe. Interactive discussion focused on the major issues determining progress: education-needs analysis, CME accreditation, evaluating and improving outcomes, the role of both the pharmaceutical industry and the patient, and setting and maintaining standards. Sessions also examined the evolution of learning and the impact of technology.
The role of the pharmaceutical industry appears central to the conundrum. CME without industry support is impossible - but pharma needs to increase its engagement with CME and to understand how it can be used to help provide greater value to its customers. Industry involvement in CME must go beyond that of a commercial organisation. To progress, pharma’s role must not be reduced solely to sponsorship to drive sales. Companies should instead take on greater responsibilities as educators.
CME is about ensuring that physicians are fit for purpose and to reassure patients that those physicians are able to manage the lifetime of their disease. Critics claim that the current structure of CME in Europe does not provide that reassurance and lacks the intellectual rigour, organisation and funding to succeed. The 2nd Annual Meeting of the European CME Forum explored strategies to improve CME across Europe: from needs analysis and programme accreditation, through funding, methodology and transparency, to implementation and evaluation. This Conference Insights report provides a concise summary of the salient issues.
All KeywordPharma publications can be purchased from ThePharmYard at www.ThePharmYard.com
NOTES
About the authors
Eugene Pozniak is Programme Director of the European CME Forum and also Managing Director of Siyemi Learning, an independent European CME provider. He has worked in the medical sector for over 20 years. Following a degree in chemistry he initially worked across various functions in marketing and medical communications. Since 2000 he has been working exclusively in CME. As well as giving advice on CME matters and managing CME-accredited meetings, Eugene developed the first pan-European CME-accredited e-learning (launched in 2002) and continues to work on national and internationally accredited e-learning. In 2006, Eugene founded Siyemi Learning, which also supports the European CMECPD Academy, an independent platform for accredited e-learning in Europe. In 2008, he partnered with Peter Llewellyn of NetworkPharma to create the European CME Forum.
David Williams pursued a career in the pharmaceutical industry for 12 years before joining the medical communications sector in 1989 to deliver educational and training multimedia programmes to clinicians, nurses and other health professionals on behalf of the UK Department of Health and Central Office of Information. Subsequently, and working as part of the Healthworld global business group, David developed a number of early intervention strategic solutions to support the commercialisation process within the international pharmaceutical sector. David then progressed to collaborate with medical and clinical associations, societies, colleges and accreditation authorities internationally to develop and deliver fair, balanced, unbiased and independent accredited events and on-line programmes in support of medical continuing professional development. David is now owner and managing director of 3C Strategy Limited, an independent communications and CME consultancy. Since becoming a consultant to the industry, David has been engaged in reviewing the medical communications sector across the whole of Europe and is currently occupied developing models for the assessment of effectiveness of medical education (CME) and its impact on day-to-day medical practice.
Written by pharmaceutical industry specialists, KeywordPharma publications are designed to be authoritative, relevant, succinct and helpful to pharmaceutical industry executives in their day-to-day work and in their longer term career development. Available to purchase individually as e-documents, they build into a specialist knowledge library for everyone working in and around the global pharmaceutical industry.
Developed and managed by NetworkPharma Ltd, ThePharmYard provides instant access to a unique database of specialist information which is particularly relevant to individuals working within the medical and pharmaceutical industries around the world. Titles from a diverse range of independent publishers are available to purchase in electronic document format for immediate access.
NetworkPharma Ltd is an independent, specialist company founded by Peter Llewellyn, to focus on novel approaches to disseminating information within the global medical and pharmaceutical industries. Peter Llewellyn previously founded and built the leading industry portal site, InPharm, which was subsequently purchased by John Wiley & Sons to manage alongside their other industry services, PharmaFile and Pharmafocus.
For more information contact:
For more information please contact us via our web site or directly contact Peter Llewellyn, Managing Director, NetworkPharma Ltd, email: peter@networkpharma.com, tel: +44 (0) 1865 865943
